Teresa A. Smolarek - Concepedia

Author

Teresa A. Smolarek

Cincinnati Children's Hospital Medical Center

Also Known As

T A Smolarek, T SMOLAREK, T Smolarek, T. A. Smolarek, T. Smolarek, T.A. Smolarek, Teresa A Smolarek, Teresa A. Smolarek, Teresa Smolarek

102

Publications

Citations

H-Index

Concepts

All Affiliations

Cincinnati Children's Hospital Medical Center Pfizer (United States)Indiana University – Purdue University Indianapolis Indiana University School of Medicine University of Cincinnati

About

Teresa A. Smolarek is an author at Cincinnati Children's Hospital Medical Center specializing in medicine, pathology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	952
2	Health Sciences	3	3	96
3	Natural Sciences	2	2	37
4	Engineering	1	1	77
5	Public Health	1	1	90

Teresa A. Smolarek

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice Vincent A. Pollack, Douglas M. Savage, Deborah A. Baker, Journal of Pharmacology and Experimental Therapeutics	1999	430
Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with Lymphangiomyomatosis Teresa A. Smolarek, Lisa L. Wessner, Francis X. McCormack, The American Journal of Human Genetics Lymphoid NeoplasiaGeneticsChromosome 16P13PathologyTsc2 Mutations	1998	315
Familial pulmonary alveolar proteinosis caused by mutations in <i>CSF2RA</i> Takuji Suzuki, Takuro Sakagami, Bruce K. Rubin, The Journal of Experimental Medicine	2008	296
DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1 Cuiping Chen, Rouchelle Mireles, Scott Campbell, Drug Metabolism and Disposition	2004	207
Regions of homozygosity identified by SNP microarray analysis aid in the diagnosis of autosomal recessive disease and incidentally detect parental blood relationships Kristen L. Sund, Sarah Zimmerman, Cameron Thomas, Genetics in Medicine Genome-wide Association StudyGenetic AnalysisGenetic TestingGenetic DisorderMedicine	2012	90
Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome Deepika Bhatla, Stella M. Davies, Shalini Shenoy, Bone Marrow Transplantation TransplantationReduced-intensity ConditioningShwachman–diamond SyndromeHematologyTransplantation Medicine	2008	84
Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping Ayman W. El‐Hattab, Teresa A. Smolarek, Martha E. Walker, Human Genetics EngineeringMedicineGeneticsNext-generation SequencingGenomic Architecture	2009	77
Cross-Species Comparison of the Metabolism and Excretion of Zoniporide: Contribution of Aldehyde Oxidase to Interspecies Differences Deepak Dalvie, Chenghong Zhang, Wei‐Chao Chen, Drug Metabolism and Disposition	2009	71
Single‐ and multiple‐dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers Keith D. Wilner, Thomas G. Tensfeldt, B. Baris, British Journal of Clinical Pharmacology	2000	68
SHROOM3 is a novel candidate for heterotaxy identified by whole exome sequencing Muhammad Tariq, John W. Belmont, Seema R. Lalani, Genome biology	2011	65

Page 1